Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
56 studies found for:    DEMENTIA, LEWY BODY
Show Display Options
Rank Status Study
21 Unknown  Construction-LBD (Constructional Apraxia in Alzheimer's Disease (AD) and Lewy Body's Dementia (LBD))
Conditions: Alzheimer's Disease;   Lewy Body's Dementia
Interventions: Other: Rey figure test;   Other: MRI
22 Completed A Genetic and Perfusion Study of Response to Cognitive Enhancers in Lewy Body Disease
Condition: Lewy Body Disease
Intervention: Drug: Cholinesterase Inhibitors (Rivastigmine, Aricept, Galantamine)
23 Recruiting Imaging Inflammation in Patients With Parkinson's Disease Dementia or Dementia With Lewy Bodies
Conditions: Diffuse Lewy Body Disease;   Dementia With Lewy Bodies;   Parkinson's Disease Dementia
Intervention: Drug: 11C-PBR28
24 Recruiting LESCOD: "Lewy Body Screening in Cognitive Disorders"
Conditions: Alzheimer Disease;   Lewy Body Disease
Intervention: Other: LeSCoD scale
25 Recruiting Study Evaluating Nelotanserin for Treatment of REM Sleep Behavior Disorder in Subjects With Dementia With Lewy Bodies
Conditions: Dementia With Lewy Bodies;   REM Sleep Behavior Disorder
Interventions: Drug: Nelotanserin;   Drug: Placebo
26 Completed Oculomotor Testing in the Differential Diagnosis of Dementia
Conditions: Lewy Body Disease;   Alzheimer's Disease
Intervention: Other: oculomotor measurements
27 Enrolling by invitation Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder
Conditions: Lewy Body Dementia;   Dementia With Lewy Bodies;   Parkinson's Disease Dementia;   Visual Hallucinations;   REM Sleep Behavior Disorder
Intervention: Drug: Nelotanserin
28 Recruiting Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia
Conditions: Alzheimer's Disease;   Dementia With Lewy Bodies;   Parkinson's Disease Dementia
Interventions: Drug: RVT-101 35 mg;   Drug: Placebo
29 Completed Dopamine Transporter Scintigraphy Imaging (DAT-Imaging) in Patients With Lewy Body Dementia
Conditions: Lewy Body Dementia;   Non-DLB Dementia;   Alzheimer’s;   Vascular Dementia
Intervention: Drug: DatSCAN
30 Completed A Trial of 18F-AV-133 and 18F-AV-45 Positron Emission Tomography (PET)
Conditions: Dementia With Lewy Bodies;   Alzheimer's Disease;   Parkinson's Disease
Interventions: Drug: 18F-AV-133;   Drug: 18F-AV-45
31 Not yet recruiting Co-LEsions in Alzheimer Disease and Related Disorders
Conditions: Alzheimer's Disease;   Cerebrovascular Disease;   Lewy Body Disease
Intervention: Radiation: SPECT-DaTscan
32 Completed Nilotinib in Cognitively Impaired Parkinson Disease Patients 001
Conditions: Parkinson's Disease;   Parkinson's Disease Dementia;   Diffuse Lewy Body Disease
Intervention: Drug: Nilotinib
33 Completed Systematic Care for Informal Caregivers of Dementia Patients: An Efficient Approach?
Conditions: Dementia, Vascular;   Dementia;   Alzheimer Disease;   Lewy Body Disease
Interventions: Behavioral: Diagnosis of caregivers' problems;   Behavioral: Professional service: treatment of problems by counseling or practical support
34 Unknown  Evaluating the Effects of Music Interventions on Hospitalised People With Dementia
Conditions: Dementia;   Alzheimer's Disease;   Dementia, Vascular;   Lewy Body Disease
Intervention: Procedure: Music Therapy
35 Enrolling by invitation Imaging of Brain Amyloid Plaques in the Aging Population
Conditions: Alzheimer's Disease;   Dementia With Lewy Bodies;   Frontotemporal Dementia;   Vascular Dementia
Interventions: Drug: Pittsburgh Compound B (C-11 PiB);   Drug: F-18 FDG;   Drug: Tau (18-F-AV-1451)
36 Recruiting Early Diagnosis of Alzheimer's Disease - a Multidisciplinary Approach
Conditions: Mild Cognitive Impairment;   Alzheimer's Disease;   Dementia With Lewy Bodies;   Vascular Dementia
Intervention:
37 Completed Assessment of Social-emotional Functioning in Neurological Diseases
Conditions: Alzheimer Disease;   Stroke;   Parkinson's Disease;   Lewy Body Dementia;   Huntington Disease
Intervention: Behavioral: Computerized tests and Electrophysiological measurements
38 Withdrawn Treating Sleep/Wake Cycle Disturbances in Basal Ganglia Disorders With Ramelteon
Conditions: Huntington's Disease;   Parkinson's Disease;   Dementia With Lewy Bodies;   Sleep Disorders;   Circadian Dysregulation
Interventions: Drug: Ramelteon;   Drug: Placebo
39 Recruiting BEAM: Brain-Eye Amyloid Memory Study
Conditions: Alzheimer's Disease;   Mild Cognitive Impairment;   Vascular Cognitive Impairment;   Parkinson's Disease;   Lewy Body Disease
Interventions: Other: Flutemetamol PET scan;   Device: Fluroescent Ligand Eye Scanning (FLES)
40 Recruiting Retinal Abnormalities as Biomarker of Disease Progression and Early Diagnosis of Parkinson Disease
Conditions: Parkinson Disease;   Multiple System Atrophy;   REM Sleep Behavior Disorder;   Pure Autonomic Failure;   Dementia With Lewy Bodies
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-56) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.